Doctoral School, University of Veterinary Medicine, Budapest, Hungary.
Department of Coagulation, Diagon Ltd., Budapest, Hungary.
PLoS One. 2019 Feb 14;14(2):e0212104. doi: 10.1371/journal.pone.0212104. eCollection 2019.
The commercially available D-dimer assays used in the clinical practice often show differences in the results, and their specificity and sensitivity are rather unsatisfactory. Our aim was to develop a new monoclonal antibody against D-dimer with a proper specificity, and estimating its suitability using in a latex agglutination diagnostic test. Monoclonal antibodies were generated using hybridoma technology. Their titer was determined by a self-developed ELISA method. The cross-reactions of the antibodies were tested. Characterization of the epitope specificity of a selected antibody was performed through digestion of D-dimer followed by Western blotting. The amino acid sequences of the active antigen fragments were determined. According to the ELISA results, 38 cell groups were constated as antibody-producing hybridomas, among them 7 gave raised titer of antibody and were cloned. Based on the cross-reaction analysis, none of the antibodies gave cross-reaction with fibrin-E and fibrinogen-E fragments but reacted with fibrin D and fibrinogen D fragments. A low cross-reaction was showed with fibrinogen and fibrin X and Y. Contrary to the others, antibody 2B9 gave no cross-reaction with fibrinogen and reacted weakly with fibrin X and Y fragments. According to the epitope analysis the antibody 2B9 binds to amino acids 94-99 and to amino acids 140-147 on the beta chain and it recognizes the amino acids 23-32 and 93-98 on the gamma chain of D-dimer. Considering the characteristics of the above mentioned monoclonal antibody 2B9, we found that it is suitable to be a basis for a D-dimer diagnostic test with proper specificity.
临床上常用的商业 D-二聚体检测方法常显示出结果的差异,其特异性和灵敏度都不尽如人意。我们的目的是开发一种具有适当特异性的新的 D-二聚体单克隆抗体,并通过乳胶凝集诊断试验来评估其适用性。使用杂交瘤技术产生单克隆抗体。通过自行开发的 ELISA 方法测定其效价。测试抗体的交叉反应性。通过 D-二聚体消化 followed by Western blotting 来测定选定抗体的表位特异性特征。确定活性抗原片段的氨基酸序列。根据 ELISA 结果,确定了 38 个细胞群为产生抗体的杂交瘤,其中 7 个产生了较高的抗体效价,并进行了克隆。根据交叉反应分析,没有抗体与纤维蛋白-E 和纤维蛋白原-E 片段发生交叉反应,但与纤维蛋白 D 和纤维蛋白原 D 片段发生反应。与其他抗体相比,抗体 2B9 与纤维蛋白原和纤维蛋白 X 和 Y 的交叉反应较低。与其他抗体不同的是,抗体 2B9 与纤维蛋白原没有交叉反应,与纤维蛋白 X 和 Y 片段的反应较弱。根据表位分析,抗体 2B9 与 D-二聚体的β链上的 94-99 位氨基酸和 140-147 位氨基酸结合,识别 γ链上的 23-32 位和 93-98 位氨基酸。考虑到上述单克隆抗体 2B9 的特点,我们发现它适合作为具有适当特异性的 D-二聚体诊断试验的基础。